Primary cardiac Sarcomas: A clinic pathological Study of Seven Cases.

Read full text Summarise with VIRAT
Authors: Hanifa BENALIKHOUDJA, Sofiane Ghemri, Nawel DJOUDI
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objectives: Primary cardiac sarcomas are extremely rare tumors associated with a dismal prognosis. This study aims to report our department’s experience in the surgical management of these tumors and to analyze their short-term outcomes. Methods: We conducted a ten-year retrospective study at the Cardiac Surgery Department of EHS Dr. Maouche. Seven patients with primary cardiac sarcoma were included. All patients underwent preoperative evaluation by echocardiography and magnetic resonance imaging (MRI) prior to surgical resection under cardiopulmonary bypass (CPB). Results: The series comprised various histological subtypes: rhabdomyosarcoma (n=2), angiosarcoma (n=1), liposarcoma (n=1), synovial sarcoma (n=1), fibrosarcoma (n=1), and one rare case of mitral valve sarcoma in a pediatric patient. Tumors were predominantly located in the right and left cardiac chambers with extensive local involvement. Despite macroscopically complete resection in most cases, the postoperative course was marked by a 100% mortality rate within two months, attributable primarily to fulminant local recurrence or metastatic progression. Conclusion: Despite advances in imaging and surgical techniques, primary cardiac sarcomas remain formidable malignancies. Surgical intervention is largely palliative, and the short-term prognosis remains catastrophic, underscoring the urgent need for early multidisciplinary management.

Fields of Study & Subjects

Cardiac tumors and thrombi Sarcoma Diagnosis and Treatment Cardiac Structural Anomalies and Repair

Publication details

Journal / source
Batna Journal of Medical Sciences (BJMS)
Volume
13
Issue
4
Publication date
1 April 2026
Language
EN